Page 80 - Read Online

Community Health 2011; 65:556-8. 37. Shin HR, Kim JY, Yun TK, Morgan G, Vainio H. The cancer-
23. Inoue M, Yoshimi I, Sobue T, Tsugane S. Influence of coffee drinking preventive potential of Panax ginseng: a review of human and
on subsequent risk of hepatocellular carcinoma: a prospective study experimental evidence. Cancer Causes Control 2000;11:565-76.
in Japan. J Natl Cancer Inst 2005;97:293-300. 38. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon
24. Inoue M, Kurahashi N, Iwasaki M, Shimazu T, Tanaka Y, Mizokami H, Surh YJ. Antioxidant and anti-tumor promoting activities
M, Tsugane S; Japan Public Health Center-Based Prospective Study of the methanol extract of heat-processed ginseng. Cancer Lett
Group. Effect of coffee and green tea consumption on the risk of liver 2000;150:41-8.
cancer: cohort analysis by hepatitis virus infection status. Cancer 39. Jing Y, Ohizumi H, Kawazoe N, Hashimoto S, Masuda Y, Nakajo
Epidemiol Biomarkers Prev 2009;18:1746-53. S, Yoshida T, Kuroiwa Y, Nakaya K. Selective inhibitory effect of
25. Johnson S, Koh WP, Wang R, Govindarajan S, Yu MC, Yuan JM. bufalin on growth of human tumor cells in vitro: association with the
Coffee consumption and reduced risk of hepatocellular carcinoma: induction of apoptosis in leukemia HL-60 cells. Jpn J Cancer Res
findings from the Singapore Chinese Health Study. Cancer Causes 1994;85:645-51.
Control 2011;22:503-10. 40. Nogawa T, Kamano Y, Yamashita A, Pettit GR. Isolation and structure
26. Hu G, Tuomilehto J, Pukkala E, Hakulinen T, Antikainen R, of five new cancer cell growth inhibitory bufadienolides from the
Vartiainen E, Jousilahti P. Joint effects of coffee consumption and Chinese Traditional Drug Ch’an Su. J Nat prod 2001;64:1148-52.
serum gamma-glutamyltransferase on the risk of liver cancer. 41. Huh JE, Kang KS, Ahn KS, Kim DH, Saiki I, Kim SH. Mylabris
Hepatology 2008;48:129-36. phalerlata induces apoptosis by caspase activation following
27. Bravi F, Cristina Bosetti C, Alessandra Tavani A, Vincenzo Bagnardi cytochrome c release and Bid cleavage. Life Sci 2003;73:2249-62.
V, Silvano Gallus S, Negri E, Franceschi S, La Vecchia C. Coffee 42. Wang CC, Chen LG, Yang LL. Cytotoxic activity of sesquiterpenoids
drinking and hepatocellular carcinoma risk: a meta-analysis. from Atractylodes ovata on leukemia cell lines. Planta Med
Hepatology 2007;46:430-5. 2002;68:204-8.
28. Larsson SC, Wolk A. Coffee consumption and risk of liver cancer: a 43. Ahn BZ, Yoon YD, Lee YH, Kim BH, Sok DE. Inhibitory effect of
meta-analysis. Gastroenterology 2007;132:1740-5. bupleuri radix saponins on adhesion of some solid tumor cells and
29. Bravi F, Bosetti C, Tavani A, Gallus S, La Vecchia C. Coffee reduces relation to hemolytic action: screening of 232 herbal drugs for anti-
risk for hepatocellular carcinoma: an updated meta-analysis. Clin cell adhesion. Planta Med 1998;64:220-4.
Gastroenterol Hepatol 2013;11:1413-21. 44. Antony S, Kuttan R, Kuttan G. Immunomodulatory activity of
30. Bamia C, Lagiou P, Jenab M, Trichopoulou A, Fedirko V, curcumin. Immunol Invest 1999;28:291-303.
Aleksandrova K, Pischon T, Overvad K, Olsen A, Tjønneland A, 45. Hirayama C, Okumura M, Tanikawa K, Yano M, Mizuta M, Ogawa
Boutron-Ruault MC, Fagherazzi G, Racine A, Kuhn T, Boeing H, N. A multicenter randomized controlled clinical trial of Shosaiko-to
Floegel A, Benetou V, Palli D, Grioni S, Panico S, Tumino R, Vineis in chronic active hepatitis. Gastroenterol Jpn 1989;24:715-9.
P, Bueno-de-Mesquita HB, Dik VK, Bhoo-Pathy N, Uiterwaal CS, 46. Oka H, Yamamoto S, Kuroki T, Harihara S, Marumo T, Kim
Weiderpass E, Lund E, Quirós JR, Zamora-Ros R, Molina-Montes SR, Monna T, Kobayashi K, Tango T. Prospective study of
E, Chirlaque MD, Ardanaz E, Dorronsoro M, Lindkvist B, Wallström chemoprevention of hepatocellular carcinoma with Sho-saiko-to (TJ-
P, Nilsson LM, Sund M, Khaw KT, Wareham N, Bradbury KE, 9). Cancer 1995;76:743-9.
Travis RC, Ferrari P, Duarte-Salles T, Stepien M, Gunter M, Murphy 47. Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M,
N, Riboli E, Trichopoulos D. Coffee, tea and decaffeinated coffee Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S. Effects of
in relation to hepatocellular carcinoma in a European population: Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.
multicentre, prospective cohort study. Int J Cancer 2015;136:1899- Hepatology 1999;29:149-0.
908. 48. Shiota G, Maeta Y, Mukoyama T, Yanagidani A, Udagawa A, Oyama
31. Setiawan VW, Wilkens LR, Lu SC, Hernandez BY, Le Marchand L, K, Yashima K, Kashimoto Y, Nakai Y, Miura T, Ito H, Murawaki Y,
Henderson BE. Association of coffee intake with reduced incidence Kawasaki H. Effects of Sho-Saiko-to on hepatocarcinogenesis and
of liver cancer and death from chronic liver disease in the US 8-hydroxy-20-deoxyguanosine formation. Hepatology 2002;35:1125-
multiethnic cohort. Gastroenterology 2015;148:118-25. 33.
32. Feld JJ, Lavoie ÉG, Michel F, Dranoff JA. I drink for my liver, 49. Zhai XF, Chen Z, Li B, Shen F, Fan J, Zhou WP, Yang YK, Xu J,
Doc: emerging evidence that coffee prevents cirrhosis. F1000Res Qin X, Li LQ, Ling CQ. Traditional herbal medicine in preventing
2015;4:95. recurrence after resection of small hepatocellular carcinoma: a
33. Petrick JL, Freedman ND, Graubard BI, Sahasrabuddhe VV, Lai GY, multicenter randomized controlled trial. J Integr Med 2013;11:90-
Alavanja MC, Beane-Freeman LE, Boggs DA, Buring JE, Chan AT, 100.
Chong DQ, Fuchs CS, Gapstur SM, Gaziano JM, Giovannucci EL, 50. Tian HQ, Li HL, Wang B, Liang GW, Huang XQ, Huang ZQ, Lang
Hollenbeck AR, King LY, Koshiol J, Lee IM, Linet MS, Palmer JR, JM, Zhang YP, Chen XZ, Chen YS. Treatment of middle/late stage
Poynter JN, Purdue MP, Robien K, Schairer C, Sesso HD, Sigurdson primary hepatic carcinoma by Chinese medicine comprehensive
AJ, Zeleniuch-Jacquotte A, Wactawski-Wende J, Campbell PT, therapy: a prospective randomized controlled study. Chin J Integr
McGlynn KA. Coffee consumption and risk of hepatocellular Med 2010;16:102-8.
carcinoma and intrahepatic cholangiocarcinoma by sex: the Liver 51. Man YN, Liu XH, Wu XZ. Chinese medicine herbal treatment based
Cancer Pooling Project. Cancer Epidemiol. Biomarkers Prev on syndrome differentiation improves the overall survival of patients
2015;24:1398-406. with unresectable hepatocellular carcinoma. Chin J Integr Med
34. Kurozawa Y, Ogimoto I, Shibata A, Nose T, Yoshimura T, Suzuki H, 2015;21:49-57.
Sakata R, Fujita Y, Ichikawa S, Iwai N, Tamakoshi A; JACC Study 52. Shu X, McCulloch M, Xiao H, Broffman M, Gao J. Chinese herbal
Group. Coffee and risk of death from hepatocellular carcinoma in a medicine and chemotherapy in the treatment of hepatocellular
large cohort study in Japan. Br J Cancer 2005;93:607-10. carcinoma: a meta-analysis of randomized controlled trials. Integr
35. Chu DT, Lepe-Zuniga J, Wong WL, LaPushin R, Mavligit GM. Cancer Ther 2005;4:219-29.
Fractionated extract of Astragalus membranaceus, a Chinese 53. McCulloch M, See C, Shu XJ, Broffman M, Kramer A, Fan WY,
medicinal herb, potentiates LAK cell cytotoxicity generated by a low Gao J, Lieb W, Shieh K, Colford JM Jr. Astragalus-based Chinese
dose of recombinant interleukin-2. J Clin Lab Immunol 1988,26:183- herbs and platinum-based chemotherapy for advanced non-small-
7. cell lung cancer: meta-analysis of randomized trials. J Clin Oncol
36. Chu DT, Wong WL, Mavligit GM. Immunotherapy with Chinese 2006,24:419-30.
medicinal herbs. I. Immune restoration of local xenogeneic graft- 54. Cho WC, Chen HY. Transcatheter arterial chemoembolization
versus-host reaction in cancer patients by fractionated Astragalus combined with or without Chinese herbal therapy for hepatocellular
membranaceus in vitro. J Clin Lab Immunol 1988,25:119-23. carcinoma: meta-analysis. Expert Opin Investig Drugs 2009;18:617-

76 Hepatoma Research | Volume 2 | March 9, 2016